Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Zeng, Zhao lei ^a   Wu, Wen jing ^a   Yang, Jing ^a   Tang, Zhen jie ^a   Chen, Dong liang ^a   Qiu, Miao zhen ^a   Luo, Hui yan ^a   Wang, Zhi qiang ^a   Jin, Ying ^a   Wang, De shen ^a   Xu, Rui hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Colorectal cancer; MAGED1; Melanoma antigen and prognosis

Indexed keywords

MELANOMA ANTIGEN; MELANOMA ANTIGEN D1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; TISSUE DIFFERENTIATION; UPREGULATION;

ANTIGENS, NEOPLASM; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865448011     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-181     Document Type: Article

References (29)

1. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991, 254:1643-1647. 10.1126/science.1840703, 1840703.
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994, 40:360-369. 10.1007/BF01246677, 7927540.
3. Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 1997, 46:397-408. 10.1006/geno.1997.5052, 9441743.
4. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998, 58:743-752.
5. Wang X, Gao X, Xu Y. MAGED1: molecular insights and clinical implications. Ann Med 2011, 43:347-355. 10.3109/07853890.2011.573806, 21612333.
6. Lucas S, Brasseur F, Boon T. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res 1999, 59:4100-4103.
7. Shiras A, Sengupta A, Shepal V. Cloning and tissue-specific gene expression studies with Dlxin-1, a newly identified transcriptional activator. Mol Cell Biol Res Commun 2001, 4:313-319. 10.1006/mcbr.2001.0298, 11529682.
8. Masuda Y, Sasaki A, Shibuya H, Ueno N, Ikeda K, Watanabe K. Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J Biol Chem 2001, 276:5331-5338. 10.1074/jbc.M008590200, 11084035.
9. Sasaki A, Masuda Y, Iwai K, Ikeda K, Watanabe K. A ring finger protein praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1. J Biol Chem 2002, 277:22541-22546. 10.1074/jbc.M109728200, 11959851.
10. Salehi AH, Xanthoudakis S, Barker PA. NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem 2002, 277:48043-48050. 10.1074/jbc.M205324200, 12376548.
11. Kendall SE, Battelli C, Irwin S, Mitchell JG, Glackin CA, Verdi JM. NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol 2005, 25:7711-7724. 10.1128/MCB.25.17.7711-7724.2005, 1190310, 16107717.
12. Wen CJ, Xue B, Qin WX, Yu M, Zhang MY, Zhao DH, Gao X, Gu JR, Li CJ. hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett 2004, 564:171-176. 10.1016/S0014-5793(04)00353-9, 15094062.
13. Tian XX, Rai D, Li J, Zou C, Bai Y, Wazer D, Band V, Gao Q. BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res 2005, 65:4747-4753. 10.1158/0008-5472.CAN-05-0018, 3295243, 15930293.
14. Reddy EM, Chettiar ST, Kaur N, Ganeshkumar R, Shepal V, Shanbhag NC, Shiras A. Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells. Cancer Gene Ther 2011, 18:206-218. 10.1038/cgt.2010.71, 21109781.
15. Chung FY, Cheng TL, Chang HJ, Chiu HH, Huang MY, Chang MS, Chen CC, Yang MJ, Wang JY, Lin SR. Differential gene expression profile of MAGE family in taiwanese patients with colorectal cancer. J Surg Oncol 2010, 102:148-153. 10.1002/jso.21580, 20648585.
16. Teng KY, Qiu MZ, Li ZH, Luo HY, Zeng ZL, Luo RZ, Zhang HZ, Wang ZQ, Li YH, Xu RH. DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med 2010, 8:126. 10.1186/1479-5876-8-126, 3003639, 21110884.
17. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, Ishikawa O, Katagiri T, Tsunoda T, Nakamura Y, Furukawa Y. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 2004, 24:305-312.
18. Bertrand M, Huijbers I, Chomez P, De Backer O. Comparative expression analysis of the MAGED1 genes during embryogenesis and brain development. Dev Dyn 2004, 230:325-334. 10.1002/dvdy.20026, 15162511.
19. Panda S, Hogenesch JB, Kay SA. Circadian rhythms from flies to human. Nature 2002, 417:329-335. 10.1038/417329a, 12015613.
20. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002, 418:935-941. 10.1038/nature00965, 12198538.
21. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003, 3:350-361. 10.1038/nrc1072, 12724733.
22. Wang X, Tang J, Xing L, Shi G, Ruan H, Gu X, Liu Z, Wu X, Gao X, Xu Y. Interaction of MAGED1 with nuclear receptors affects circadian clock function. EMBO J 2010, 29:1389-1400. 10.1038/emboj.2010.34, 2868574, 20300063.
23. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111:41-50. 10.1016/S0092-8674(02)00961-3, 12372299.
24. Oda A, Katayose Y, Yabuuchi S, Yamamoto K, Mizuma M, Shirasou S, Onogawa T, Ohtsuka H, Yoshida H, Hayashi H, et al. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res 2009, 29:1201-1209.
25. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 2007, 14:815-818. 10.1038/sj.cgt.7701061, 17589433.
26. Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, Nozaki A, Numata K, Shiozawa M, Rino Y, Tanaka K, et al. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 2011, 25:1439-1446.
27. Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem 2010, 148:319-326. 10.1093/jb/mvq069, 20576619.
28. Hanoun M, Eisele L, Suzuki M, Greally JM, Huttmann A, Aydin S, Scholtysik R, Klein-Hitpass L, Duhrsen U, Durig J. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 2012, 7:e34347. 10.1371/journal.pone.0034347, 3314606, 22470559.
29. Iurisci I, Filipski E, Sallam H, Harper F, Guettier C, Maire I, Hassan M, Iacobelli S, Levi F. Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol Int 2009, 26:1169-1188.